Renaissance Technologies
PRCT icon

Renaissance Technologies’s Procept Biorobotics PRCT Stock Holding History

Renaissance Technologies’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-116,166
Closed -$2.91M – 3539
2026
Q1 		$2.91M Sell
116,166
-1,300
-1% -$36.6K ﹤0.01% 1680
2025
Q4 		$3.7M Buy
+117,466
New +$3.9M 0.01% 1502
2025
Q2 		– Sell
-314,466
Closed -$18.3M – 3818
2025
Q1 		$18.3M Buy
314,466
+36,000
+13% +$2.46M 0.03% 700
2024
Q4 		$22.4M Buy
+278,466
New +$23.8M 0.03% 614
2024
Q3 		– Sell
-45,966
Closed -$2.81M – 3806
2024
Q2 		$2.81M Buy
+45,966
New +$2.73M ﹤0.01% 1660
2023
Q2 		– Sell
-63,566
Closed -$1.8M – 4196
2023
Q1 		$1.8M Buy
+63,566
New +$2.24M ﹤0.01% 2090
2022
Q1 		– Sell
-179,300
Closed -$4.48M – 4375
2021
Q4 		$4.48M Buy
+179,300
New +$6.63M 0.01% 1602

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies's PRCT Position: Q2 2026 in Review

Renaissance Technologies sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 116,166 shares — an estimated $2.91M sold.

Renaissance Technologies first reported a position in PRCT in Q4 2021 and held it in 7 quarters. The position peaked at $22.4M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Renaissance Technologies reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 116,166 Procept Biorobotics shares in Q2 2026, an estimated $2.91M.
  • Renaissance Technologies first reported a position in Procept Biorobotics in Q4 2021 and held it in 7 quarters.
  • Renaissance Technologies's Procept Biorobotics position peaked at $22.4M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.